These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21668397)

  • 21. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
    Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ
    Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence and Severity of Donor Lymphocyte Infusion-Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Yu WJ; Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2019 May; 25(5):912-920. PubMed ID: 30485788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.
    Lai P; Weng J; Lu Z; Guo R; Luo C; Wu S; Ling W; Geng S; Du X
    DNA Cell Biol; 2011 Dec; 30(12):1019-25. PubMed ID: 21682596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune modulation and chronic graft-versus-host disease.
    Soiffer R
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S66-S69. PubMed ID: 18724307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.
    Weissinger EM; Human C; Metzger J; Hambach L; Wolf D; Greinix HT; Dickinson AM; Mullen W; Jonigk D; Kuzmina Z; Kreipe H; Schweier P; Böhm O; Türüchanow I; Ihlenburg-Schwarz D; Raad J; Durban A; Schiemann M; Könecke C; Diedrich H; Holler E; Beutel G; Krauter J; Ganser A; Stadler M
    Leukemia; 2017 Mar; 31(3):654-662. PubMed ID: 27677743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine models of chronic graft-versus-host disease: insights and unresolved issues.
    Chu YW; Gress RE
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):365-78. PubMed ID: 18342778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cells in chronic graft-versus-host disease.
    McManigle W; Youssef A; Sarantopoulos S
    Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
    Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
    Front Immunol; 2019; 10():1879. PubMed ID: 31507582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing response of therapy for acute and chronic graft-versus-host disease.
    Goldberg JD; Giralt S
    Expert Rev Hematol; 2013 Feb; 6(1):103-7. PubMed ID: 23373785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival.
    Kordelas L; Schwich E; Lindemann M; Heinemann FM; Buttkereit U; Horn PA; Beelen DW; Rebmann V
    Front Immunol; 2019; 10():3027. PubMed ID: 31998310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
    MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease.
    Sonntag K; Eckert F; Welker C; Müller H; Müller F; Zips D; Sipos B; Klein R; Blank G; Feuchtinger T; Schumm M; Handgretinger R; Schilbach K
    J Autoimmun; 2015 Aug; 62():55-66. PubMed ID: 26143958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
    Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q
    J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia.
    Kuzmina Z; Greinix HT; Weigl R; Körmöczi U; Rottal A; Frantal S; Eder S; Pickl WF
    Blood; 2011 Feb; 117(7):2265-74. PubMed ID: 21063025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.
    Wang KS; Kim HT; Nikiforow S; Heubeck AT; Ho VT; Koreth J; Alyea EP; Armand P; Blazar BR; Soiffer RJ; Antin JH; Cutler CS; Ritz J
    Blood; 2017 Dec; 130(26):2889-2899. PubMed ID: 29138220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study.
    Prenc E; Pulanic D; Pucic-Bakovic M; Ugrina I; Desnica L; Milosevic M; Pirsl F; Mitchell S; Rose J; Vrhovac R; Nemet D; Lauc G; Pavletic SZ
    Front Immunol; 2021; 12():633214. PubMed ID: 34335560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H
    Front Immunol; 2020; 11():1505. PubMed ID: 32849514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D
    Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic graft-versus-host disease: diagnosis and treatment].
    Inamoto Y
    Rinsho Ketsueki; 2018; 59(5):549-556. PubMed ID: 29877246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling Chronic Graft Versus Host Disease in Mice Using Allogeneic Bone Marrow and Splenocyte Transfer.
    Schroeder MA; Ashami K; Staser K
    Curr Protoc Pharmacol; 2018 Dec; 83(1):e47. PubMed ID: 30204297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.